M&A Deal Summary |
|
---|---|
Date | 2019-06-24 |
Target | Trimb Healthcare AB |
Sector | Life Science |
Buyer(s) | Karo Healthcare |
Sellers(s) | Avista Healthcare Partners |
Deal Type | Add-on Acquisition |
Deal Value | 3.4B SEK |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1987 |
Sector | Life Science |
Employees | 225 |
Revenue | 3.0B SEK (2021) |
Karo Healthcare is a specialty pharmaceutical company in the Nordics. The company develops and markets products for pharmacies and directly to the healthcare sector. The product portfolio includes over-the-counter and prescription pharmaceuticals as well as medical devices. Karo Healthcare was incorporated in 1987 and is based in Stockholm, Sweden.
DEAL STATS | # |
---|---|
Overall | 4 of 5 |
Sector (Life Science) | 3 of 3 |
Type (Add-on Acquisition) | 3 of 4 |
Country (Sweden) | 4 of 4 |
Year (2019) | 1 of 1 |
Size (of disclosed) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-11-01 |
Biophausia AB
Stockholm, Sweden Biophausia AB is a pharmaceutical company. Biophausia provides cost-effective pharmaceuticals and focuses on three fields: generic products, niche products and original drugs. |
Buy | kr908M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-11-23 |
Sylphar
Deurle, Belgium Sylphar is a fast-growing OTC company with a portfolio of brands in the oral beauty, oral therapy and medicated skincare market segments. Sylphar was founded 2007 and is based in Deurle, Belgium. |
Buy | - |
Category | Private Equity Firm |
---|---|
Founded | 2005 |
PE ASSETS | 8.0B USD |
Size | Mega |
Type | Sector Focused |
Avista Capital Partners is a private investment firm formed by a group of professionals with roots from DLJ Merchant Banking Partners. Avista makes controlling and minority investments in US based energy, healthcare, and media companies with revenues greater than $25 million. Typical transactions include leverage buyouts, build-ups, and growth capital financings. Avista Capital was formed in 2005 and is based in New York City with an additional office in Houston, Texas.
DEAL STATS | # |
---|---|
Overall | 27 of 30 |
Sector (Life Science) | 5 of 7 |
Type (Add-on Acquisition) | 13 of 15 |
Country (Sweden) | 1 of 1 |
Year (2019) | 1 of 1 |
Size (of disclosed) | 7 of 11 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2018-12-10 |
Organogenesis
Canton, Massachusetts, United States Organogenesis is a provider of regenerative medicine, offering a portfolio of bioactive and acellular biomaterials products for advanced wound care, orthopedics and spine. Organogenesis was established in 1985 and is headquartered in Canton, Massachusetts. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-09-03 |
GCM Holding
Union, California, United States GCM Holding is a manufacturer of low-to-medium volume, mission-critical precision machined components and assemblies. Based near Chicago’s O’Hare airport, the Company serves large, market customers in the energy, medical equipment, scientific laboratory, and industrial end markets. GCM Holding was founded in 1978 and is based in Union, California. |
Buy | - |